Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

'Dhurandhar 2 Can Permanently Destroy Pan-India South Films,' Says RGV

As Dhurandhar: The Revenge prepares for its theatrical release on March 19, Ram Gopal Varma has made a bold claim about the film. The filmm...